Carna Biosciences, Inc. (4572)(製薬・医療分野):企業M&A動向

◆英語タイトル:Carna Biosciences, Inc. (4572) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:GDPH82659D
◆発行会社(調査会社):GlobalData
◆発行日:2015年3月13日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Carna Biosciences, Inc. is a biotechnology company. The company discovers and develops drugs for the treatment of patients with cancer and anti-inflammatory diseases by using QuickScout, which is a kinase drug discovery platform. Carna Biosciences’ products and services include kinase proteins, biotinylated kinases, profiling services, RPPA cell signaling analysis service, live-cell kinase assays, claricell kinase cell-based assay services, crystallography, assay development and substrates. Carna Biosciences provides a range of protein kinases, which include cytoplasmic tyrosine kinase, receptor tyrosine kinase and ser and threonine kinases. The company’s profiling services include pre-selected panels, service flow, application form, samples shipping instructions and yearly schedule of services. The company’s subsidiaries include Kinase Logistics ApS, Shanghai Universal Biotech Company, Biogenuix Medsystems Pvt. Ltd., CarnaBio USA, Inc., and EUROMEDEX. Carna Biosciences is headquartered in Kobe, Japan.

Carna Biosciences, Inc. (4572) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
Carna Biosciences, Inc., Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015 6
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 8
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015 9
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Netherlands Translational Research Center Enters Into Co-Marketing Agreement With Carna Biosciences 10
TCG Lifesciences Enters Into Strategic Alliance With Carna Biosciences 11
Equity Offering 12
Carna Biosciences Completes Private Placement Of US$0.26 Million 12
Carna Biosciences Completes Public Offering Of US$3.49 Million 13
Acquisition 14
Carna Biosciences Announces Stock Exchange Ratio To Acquire ProbeX 14
Carna Biosciences, Inc. – Key Competitors 15
Key Employees 16
Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Key Facts, 2014 1
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
Carna Biosciences, Inc., Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015 6
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
Carna Biosciences, Inc., Deals By Therapy Area, 2009 to YTD 2015 8
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015 9
Netherlands Translational Research Center Enters Into Co-Marketing Agreement With Carna Biosciences 10
TCG Lifesciences Enters Into Strategic Alliance With Carna Biosciences 11
Carna Biosciences Completes Private Placement Of US$0.26 Million 12
Carna Biosciences Completes Public Offering Of US$3.49 Million 13
Carna Biosciences Announces Stock Exchange Ratio To Acquire ProbeX 14
Carna Biosciences, Inc., Key Competitors 15
Carna Biosciences, Inc., Key Employees 16
Carna Biosciences, Inc., Subsidiaries 17

List of Figures
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 1
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 1
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 1
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 1
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 6
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 8

★海外企業調査レポート[Carna Biosciences, Inc. (4572)(製薬・医療分野):企業M&A動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Active Motif Inc:企業のM&A・提携動向(医療分野)
    Summary Active Motif Inc (Active Motif) is a biotechnology company that develops and delivers biological research tools and techniques which supports in protein analysis and biological function. The company’s products include antibodies, extracts, fluorescent dyes, kits, and recombinant proteins. It …
  • Adecco Group AG :企業の戦略・SWOT・財務分析
    SummaryAdecco Group AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Finding …
  • Caribbean Utilities Company, Ltd.:企業の発電所・SWOT分析2018
    Caribbean Utilities Company, Ltd. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Eesti Energia AS:電力:M&Aディール及び事業提携情報
    Summary Eesti Energia AS (Eesti Energia) is an international energy company. It offers energy solutions ranging from electricity, heat and fuel production to sales, customer service and ancillary energy services among others. Eesti Energia sells electricity to the Baltic retail customers and the who …
  • Stavropolenergosbyt (STSB):企業の財務及び戦略的SWOT分析
    Summary Stavropolenergosbyt is an energy company that supplies electricity in the Stavropol Region. Its services include electricity distribution, payment information, energy survey, energy saving, energy audit and inspection. Stavropolenergosbyt offers equipment and instruments for non-destructive …
  • Trinity Exploration and Production plc (TRIN):石油・ガス:M&Aディール及び事業提携情報
    Summary Trinity Exploration and Production plc (Trinity), formerly Bayfield Energy Holdings plc is an oil and gas company that explores and develops onshore and offshore projects. The company’s activities include production, development, exploration and extraction of hydrocarbons. It operates in Tri …
  • Beiqi Foton Motor Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Beiqi Foton Motor Co., Ltd. Mer …
  • Saudi Ceramic Companyの企業概要及び財務/SWOT分析
    Saudi Ceramic Company Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Saudi Ceramic Company annual and quarterly forecasts made by stock market experts. The report also enabl …
  • Tower Bersama Infrastructure Tbkの企業概要及び財務/SWOT分析
    Tower Bersama Infrastructure Tbk Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual an …
  • NovaGold Resources, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' NovaGold Resources, Inc. Merger …
  • Dolan Media Company:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Dolan Media Company Mergers and …
  • Corus Group plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Corus Group plc Mergers and Acq …
  • Live Nation Entertainment, Inc.:企業のM&A・提携・投資分析
    Live Nation Entertainment, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Live Nation Entertainment, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • TauRx Pharmaceuticals Ltd:医療機器:M&Aディール及び事業提携情報
    Summary TauRx Pharmaceuticals Ltd (TauRx) discovers, develops and commercializes treatments and diagnostics for Alzheimer's disease and other neurodegenerative diseases. Its pipeline products include LMTX, a tau aggregation inhibitor (TAI) for Alzheimer’s and Behavioural variant frontotemporal demen …
  • NewSoft Technology Corporation (5202):企業財務及び戦略的SWOT分析
    Summary NewSoft Technology Corporation (NewSoft) is an information technology company that offers software and hardware integration solutions. The company’s products include digital document, digital recognition, digital image and mobile app solutions. It offers personal development services such as …
  • UpFront Chromatography A/S:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' UpFront Chromatography A/S Merg …
  • aycan Digitalsysteme GmbH:企業のM&A・提携動向(医療機器分野)
    Summary aycan Digitalsysteme GmbH (aycan) is a medical device company that offers medical imaging solutions. The company provides solutions for archiving, viewing, and printing medical images and information that improve workflow efficiency and drive down costs. Its key products include aycan store …
  • Huron Consulting Group, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Huron Consulting Group, Inc. Me …
  • Strayer Education, Inc. (STRA):企業概要、財務及び戦略的SWOT分析
    Summary Strayer Education, Inc. (Strayer) is an education service provider. The institution offers undergraduate and graduate degree programs. Its degree programs include business administration, accounting, computer information systems, and education and public administration. Strayer provides cour …
  • Agriterra Limited (AGTA):企業の財務及び戦略的SWOT分析
    Summary Agriterra Limited (Agriterra) is an agricultural investment company that invests in agricultural activities and sustainable development. The company’s products include beef, cocoa, maize and palm oil. It offers business in the fields of beef; that conducts cattle ranching, feedlot, abattoir …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆